CD96 and breast cancer: Notably, the data also revealed that these subtypes of CD8+ T cells positively expressed T cell exhaustion‐related inhibitory receptors, including LAG3, TIGIT, and CD96, indicating that these CD8+ T cells were exhausted after the initial activation step in the liver and brain metastases of breast cancer (Figure 4f,g).